These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 37990341)
1. Rare germline variants in POLE and POLD1 encoding the catalytic subunits of DNA polymerases ε and δ in glioma families. Weber CAM; Krönke N; Volk V; Auber B; Förster A; Trost D; Geffers R; Esmaeilzadeh M; Lalk M; Nabavi A; Samii A; Krauss JK; Feuerhake F; Hartmann C; Wiese B; Brand F; Weber RG Acta Neuropathol Commun; 2023 Nov; 11(1):184. PubMed ID: 37990341 [TBL] [Abstract][Full Text] [Related]
2. POLE and POLD1 germline exonuclease domain pathogenic variants, a rare event in colorectal cancer from the Middle East. Siraj AK; Bu R; Iqbal K; Parvathareddy SK; Masoodi T; Siraj N; Al-Rasheed M; Kong Y; Ahmed SO; Al-Obaisi KAS; Victoria IG; Arshad M; Al-Dayel F; Abduljabbar A; Ashari LH; Al-Kuraya KS Mol Genet Genomic Med; 2020 Aug; 8(8):e1368. PubMed ID: 32567205 [TBL] [Abstract][Full Text] [Related]
3. Low frequency of POLD1 and POLE exonuclease domain variants in patients with multiple colorectal polyps. Elsayed FA; Tops CMJ; Nielsen M; Ruano D; Vasen HFA; Morreau H; J Hes F; van Wezel T Mol Genet Genomic Med; 2019 Apr; 7(4):e00603. PubMed ID: 30827058 [TBL] [Abstract][Full Text] [Related]
4. Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas. Palles C; Cazier JB; Howarth KM; Domingo E; Jones AM; Broderick P; Kemp Z; Spain SL; Guarino E; Salguero I; Sherborne A; Chubb D; Carvajal-Carmona LG; Ma Y; Kaur K; Dobbins S; Barclay E; Gorman M; Martin L; Kovac MB; Humphray S; ; ; Lucassen A; Holmes CC; Bentley D; Donnelly P; Taylor J; Petridis C; Roylance R; Sawyer EJ; Kerr DJ; Clark S; Grimes J; Kearsey SE; Thomas HJ; McVean G; Houlston RS; Tomlinson I Nat Genet; 2013 Feb; 45(2):136-44. PubMed ID: 23263490 [TBL] [Abstract][Full Text] [Related]
5. POLE and POLD1 mutations in 529 kindred with familial colorectal cancer and/or polyposis: review of reported cases and recommendations for genetic testing and surveillance. Bellido F; Pineda M; Aiza G; Valdés-Mas R; Navarro M; Puente DA; Pons T; González S; Iglesias S; Darder E; Piñol V; Soto JL; Valencia A; Blanco I; Urioste M; Brunet J; Lázaro C; Capellá G; Puente XS; Valle L Genet Med; 2016 Apr; 18(4):325-32. PubMed ID: 26133394 [TBL] [Abstract][Full Text] [Related]
6. Recommendations for the classification of germline variants in the exonuclease domain of POLE and POLD1. Mur P; Viana-Errasti J; García-Mulero S; Magraner-Pardo L; Muñoz IG; Pons T; Capellá G; Pineda M; Feliubadaló L; Valle L Genome Med; 2023 Oct; 15(1):85. PubMed ID: 37848928 [TBL] [Abstract][Full Text] [Related]
7. New insights into POLE and POLD1 germline mutations in familial colorectal cancer and polyposis. Valle L; Hernández-Illán E; Bellido F; Aiza G; Castillejo A; Castillejo MI; Navarro M; Seguí N; Vargas G; Guarinos C; Juarez M; Sanjuán X; Iglesias S; Alenda C; Egoavil C; Segura Á; Juan MJ; Rodriguez-Soler M; Brunet J; González S; Jover R; Lázaro C; Capellá G; Pineda M; Soto JL; Blanco I Hum Mol Genet; 2014 Jul; 23(13):3506-12. PubMed ID: 24501277 [TBL] [Abstract][Full Text] [Related]
8. Solving the enigma of POLD1 p.V295M as a potential cause of increased cancer risk. Mur P; Magraner-Pardo L; García-Mulero S; Díez-Villanueva A; Del Valle J; Ezquerro E; Lázaro C; Capellá G; Moreno V; Sanz-Pamplona R; Pons T; Valle L Eur J Hum Genet; 2022 Apr; 30(4):485-489. PubMed ID: 34285382 [TBL] [Abstract][Full Text] [Related]
9. POLE/POLD1 mutation and tumor immunotherapy. Ma X; Dong L; Liu X; Ou K; Yang L J Exp Clin Cancer Res; 2022 Jul; 41(1):216. PubMed ID: 35780178 [TBL] [Abstract][Full Text] [Related]
10. Germline variants in POLE are associated with early onset mismatch repair deficient colorectal cancer. Elsayed FA; Kets CM; Ruano D; van den Akker B; Mensenkamp AR; Schrumpf M; Nielsen M; Wijnen JT; Tops CM; Ligtenberg MJ; Vasen HF; Hes FJ; Morreau H; van Wezel T Eur J Hum Genet; 2015 Aug; 23(8):1080-4. PubMed ID: 25370038 [TBL] [Abstract][Full Text] [Related]
11. Mutation spectrum of POLE and POLD1 mutations in South East Asian women presenting with grade 3 endometrioid endometrial carcinomas. Wong A; Kuick CH; Wong WL; Tham JM; Mansor S; Loh E; Jain S; Vikas NN; Tan SH; Chan SH; Li ST; Chew SH; Hong W; Ngeow J Gynecol Oncol; 2016 Apr; 141(1):113-20. PubMed ID: 26748215 [TBL] [Abstract][Full Text] [Related]
12. Role of POLE and POLD1 in familial cancer. Mur P; García-Mulero S; Del Valle J; Magraner-Pardo L; Vidal A; Pineda M; Cinnirella G; Martín-Ramos E; Pons T; López-Doriga A; Belhadj S; Feliubadaló L; Munoz-Torres PM; Navarro M; Grau E; Darder E; Llort G; Sanz J; Ramón Y Cajal T; Balmana J; Brunet J; Moreno V; Piulats JM; Matías-Guiu X; Sanz-Pamplona R; Aligué R; Capellá G; Lázaro C; Valle L Genet Med; 2020 Dec; 22(12):2089-2100. PubMed ID: 32792570 [TBL] [Abstract][Full Text] [Related]
13. DNA polymerase ε and δ exonuclease domain mutations in endometrial cancer. Church DN; Briggs SE; Palles C; Domingo E; Kearsey SJ; Grimes JM; Gorman M; Martin L; Howarth KM; Hodgson SV; ; Kaur K; Taylor J; Tomlinson IP Hum Mol Genet; 2013 Jul; 22(14):2820-8. PubMed ID: 23528559 [TBL] [Abstract][Full Text] [Related]
14. Frequency and phenotypic spectrum of germline mutations in POLE and seven other polymerase genes in 266 patients with colorectal adenomas and carcinomas. Spier I; Holzapfel S; Altmüller J; Zhao B; Horpaopan S; Vogt S; Chen S; Morak M; Raeder S; Kayser K; Stienen D; Adam R; Nürnberg P; Plotz G; Holinski-Feder E; Lifton RP; Thiele H; Hoffmann P; Steinke V; Aretz S Int J Cancer; 2015 Jul; 137(2):320-31. PubMed ID: 25529843 [TBL] [Abstract][Full Text] [Related]
15. Risk of colorectal cancer for carriers of a germ-line mutation in POLE or POLD1. Buchanan DD; Stewart JR; Clendenning M; Rosty C; Mahmood K; Pope BJ; Jenkins MA; Hopper JL; Southey MC; Macrae FA; Winship IM; Win AK Genet Med; 2018 Aug; 20(8):890-895. PubMed ID: 29120461 [TBL] [Abstract][Full Text] [Related]
16. Combined mismatch repair and POLE/POLD1 defects explain unresolved suspected Lynch syndrome cancers. Jansen AM; van Wezel T; van den Akker BE; Ventayol Garcia M; Ruano D; Tops CM; Wagner A; Letteboer TG; Gómez-García EB; Devilee P; Wijnen JT; Hes FJ; Morreau H Eur J Hum Genet; 2016 Jul; 24(7):1089-92. PubMed ID: 26648449 [TBL] [Abstract][Full Text] [Related]
17. Discovery of recessive effect of human polymerase δ proofreading deficiency through mutational analysis of POLD1-mutated normal and cancer cells. Andrianova MA; Seplyarskiy VB; Terradas M; Sánchez-Heras AB; Mur P; Soto JL; Aiza G; Borràs E; Kondrashov FA; Kondrashov AS; Bazykin GA; Valle L Eur J Hum Genet; 2024 Jul; 32(7):837-845. PubMed ID: 38658779 [TBL] [Abstract][Full Text] [Related]
18. Germline and somatic polymerase ε and δ mutations define a new class of hypermutated colorectal and endometrial cancers. Briggs S; Tomlinson I J Pathol; 2013 Jun; 230(2):148-53. PubMed ID: 23447401 [TBL] [Abstract][Full Text] [Related]
19. Increased somatic mutation burdens in normal human cells due to defective DNA polymerases. Robinson PS; Coorens THH; Palles C; Mitchell E; Abascal F; Olafsson S; Lee BCH; Lawson ARJ; Lee-Six H; Moore L; Sanders MA; Hewinson J; Martin L; Pinna CMA; Galavotti S; Rahbari R; Campbell PJ; Martincorena I; Tomlinson I; Stratton MR Nat Genet; 2021 Oct; 53(10):1434-1442. PubMed ID: 34594041 [TBL] [Abstract][Full Text] [Related]
20. High mutational burden in colorectal carcinomas with monoallelic POLE mutations: absence of allelic loss and gene promoter methylation. Hühns M; Nürnberg S; Kandashwamy KK; Maletzki C; Bauer P; Prall F Mod Pathol; 2020 Jun; 33(6):1220-1231. PubMed ID: 31857678 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]